Question 1

What is the catalog number for GRO Alpha Polyclonal Antibody PE Conjugated?

Accepted Answer

The catalog number for GRO Alpha Polyclonal Antibody PE Conjugated is orb1541288.

Question 2

What sizes are available for GRO Alpha Polyclonal Antibody PE Conjugated?

Accepted Answer

GRO Alpha Polyclonal Antibody PE Conjugated is available in the following size(s): 100 µL.

Question 3

Is GRO Alpha Polyclonal Antibody PE Conjugated in stock?

Accepted Answer

GRO Alpha Polyclonal Antibody PE Conjugated is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is GRO Alpha Polyclonal Antibody PE Conjugated used for?

Accepted Answer

GRO Alpha Polyclonal Antibody PE Conjugated

Question 5

Do you provide a Certificate of Analysis (CoA) for this product?

Accepted Answer

A Certificate of Analysis is available for most products upon request. Contact our support team with the lot number to obtain the relevant CoA.

Question 6

Is this product suitable for live cell imaging?

Accepted Answer

Suitability for live cell imaging depends on the specific reagent and conjugate used. Check the datasheet for imaging-specific validation, or contact us for guidance.

Question 7

Is this product covered by a money-back guarantee?

Accepted Answer

Yes, we guarantee a full refund or store credit if this product arrives damaged beyond usability, or has a genuine performance issue under proper usage and storage, provided you report it immediately with evidence. Claims after the expiration date or due to improper storage after receipt are excluded.

GRO Alpha Polyclonal Antibody PE Conjugated

Product Specifications

UniProt

Reactivity

Clonality

Conjugation

Source

Field of Research

Dilution

Storage Conditions

Notes

Tested Applications

Host or Source

Frequently Asked Questions

Explore Other Products

Cadherin-pan Antibody

Sodium Diformamide

SGLT2 (SLC5A2) (NM_003041) Human Over-expression Lysate

(-)-Lentiginosine

C1orf124 (SPRTN) Rabbit Polyclonal Antibody

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2743), CF594 conjugate, 0.1mg/mL